Cargando…

Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer

BACKGROUND: Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) is technically challenging but increasingly performed in specialist centres. The aim of this study was to compare outcomes of exenteration over time. METHODS: This was a multicentre r...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677093/
https://www.ncbi.nlm.nih.gov/pubmed/31388644
http://dx.doi.org/10.1002/bjs5.50153
_version_ 1783440884795179008
collection PubMed
description BACKGROUND: Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) is technically challenging but increasingly performed in specialist centres. The aim of this study was to compare outcomes of exenteration over time. METHODS: This was a multicentre retrospective study of patients who underwent exenteration for LARC and LRRC between 2004 and 2015. Surgical outcomes, including rate of bone resection, flap reconstruction, margin status and transfusion rates, were examined. Outcomes between higher‐ and lower‐volume centres were also evaluated. RESULTS: Some 2472 patients underwent pelvic exenteration for LARC and LRRC across 26 institutions. For LARC, rates of bone resection or flap reconstruction increased from 2004 to 2015, from 3·5 to 12·8 per cent, and from 12·0 to 29·4 per cent respectively. Fewer units of intraoperative blood were transfused over this interval (median 4 to 2 units; P = 0·040). Subgroup analysis showed that bone resection and flap reconstruction rates increased in lower‐ and higher‐volume centres. R0 resection rates significantly increased in low‐volume centres but not in high‐volume centres over time (low‐volume: from 62·5 to 80·0 per cent, P = 0·001; high‐volume: from 83·5 to 88·4 per cent, P = 0·660). For LRRC, no significant trends over time were observed for bone resection or flap reconstruction rates. The median number of units of intraoperative blood transfused decreased from 5 to 2·5 units (P < 0·001). R0 resection rates did not increase in either low‐volume (from 51·7 to 60·4 per cent; P = 0·610) or higher‐volume (from 48·6 to 65·5 per cent; P = 0·100) centres. No significant differences in length of hospital stay, 30‐day complication, reintervention or mortality rates were observed over time. CONCLUSION: Radical resection, bone resection and flap reconstruction rates were performed more frequently over time, while transfusion requirements decreased.
format Online
Article
Text
id pubmed-6677093
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley & Sons, Ltd
record_format MEDLINE/PubMed
spelling pubmed-66770932019-08-06 Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer BJS Open Original Articles BACKGROUND: Pelvic exenteration for locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) is technically challenging but increasingly performed in specialist centres. The aim of this study was to compare outcomes of exenteration over time. METHODS: This was a multicentre retrospective study of patients who underwent exenteration for LARC and LRRC between 2004 and 2015. Surgical outcomes, including rate of bone resection, flap reconstruction, margin status and transfusion rates, were examined. Outcomes between higher‐ and lower‐volume centres were also evaluated. RESULTS: Some 2472 patients underwent pelvic exenteration for LARC and LRRC across 26 institutions. For LARC, rates of bone resection or flap reconstruction increased from 2004 to 2015, from 3·5 to 12·8 per cent, and from 12·0 to 29·4 per cent respectively. Fewer units of intraoperative blood were transfused over this interval (median 4 to 2 units; P = 0·040). Subgroup analysis showed that bone resection and flap reconstruction rates increased in lower‐ and higher‐volume centres. R0 resection rates significantly increased in low‐volume centres but not in high‐volume centres over time (low‐volume: from 62·5 to 80·0 per cent, P = 0·001; high‐volume: from 83·5 to 88·4 per cent, P = 0·660). For LRRC, no significant trends over time were observed for bone resection or flap reconstruction rates. The median number of units of intraoperative blood transfused decreased from 5 to 2·5 units (P < 0·001). R0 resection rates did not increase in either low‐volume (from 51·7 to 60·4 per cent; P = 0·610) or higher‐volume (from 48·6 to 65·5 per cent; P = 0·100) centres. No significant differences in length of hospital stay, 30‐day complication, reintervention or mortality rates were observed over time. CONCLUSION: Radical resection, bone resection and flap reconstruction rates were performed more frequently over time, while transfusion requirements decreased. John Wiley & Sons, Ltd 2019-03-06 /pmc/articles/PMC6677093/ /pubmed/31388644 http://dx.doi.org/10.1002/bjs5.50153 Text en © 2019 The Authors. BJS Open published by John Wiley & Sons Ltd on behalf of BJS Society Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
title Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
title_full Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
title_fullStr Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
title_full_unstemmed Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
title_short Changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
title_sort changing outcomes following pelvic exenteration for locally advanced and recurrent rectal cancer
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6677093/
https://www.ncbi.nlm.nih.gov/pubmed/31388644
http://dx.doi.org/10.1002/bjs5.50153
work_keys_str_mv AT changingoutcomesfollowingpelvicexenterationforlocallyadvancedandrecurrentrectalcancer